Semi-Annual Consolidated Statement Of Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7613094

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
993,350,000,000 JPY
779,194,000,000 JPY
Cost of sales
335,057,000,000 JPY
268,868,000,000 JPY
Ordinary profit (loss)
414,116,000,000 JPY
290,823,000,000 JPY
Gross profit (loss)
658,292,000,000 JPY
510,326,000,000 JPY
Extraordinary income
707,000,000 JPY
6,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
247,979,000,000 JPY
222,217,000,000 JPY
Extraordinary losses
6,871,000,000 JPY
2,364,000,000 JPY
Profit (loss) before income taxes
407,952,000,000 JPY
288,465,000,000 JPY
Operating profit (loss)
410,313,000,000 JPY
288,109,000,000 JPY
Income taxes - current
122,497,000,000 JPY
86,644,000,000 JPY
Non-operating income
Non-operating income
5,362,000,000 JPY
5,109,000,000 JPY
Income taxes - deferred
-9,258,000,000 JPY
-5,974,000,000 JPY
Non-operating expenses
Interest expenses
3,000,000 JPY
3,000,000 JPY
Non-operating expenses
1,559,000,000 JPY
2,395,000,000 JPY
Income taxes
113,239,000,000 JPY
80,671,000,000 JPY
Profit (loss)
294,713,000,000 JPY
294,713,000,000 JPY
294,713,000,000 JPY
294,713,000,000 JPY
207,795,000,000 JPY
207,795,000,000 JPY
207,795,000,000 JPY
207,795,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
624,000,000 JPY
3,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
492,000,000 JPY
1,000,000 JPY
Impairment losses
1,812,000,000 JPY
275,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.